Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
14 Jul, 26
ESHRE 2026
Key highlights of the sessions on global and socio-cultural aspects of infertility presented at ESHRE from 5th to 8th July 2026 in London, UK.
14 Jul, 26ESHRE 2026
Key highlights of the sessions on fertility preservation presented at ESHRE from 5th to 8th July 2026 in London, UK.
16 Jul, 26Indian J. Crit Care ...
- Review of 52 studies informed GRADE-based treatment recommendations for CRE, CRAB, and CRPA.
- For CRE, BL/BLI regimens improved cure (58.7% vs 48.9%) and reduced adverse events versus polymyxins.
- For CRAB, sulbactam-based therapy improved cure (61.9% vs 39.7%) and lowered nephrotoxicity.
- For CRPA, efficacy was similar, but polymyxins caused more toxicity; non-polymyxin regimens were preferred.
16 Jul, 26Diabetes Technol The...
- In a longitudinal study of 190 insulin-treated patients with diabetes followed for a median of 7.3 years, each 10% point increase in CGM time in range (TIR) was associated with an 11.8% reduction in UACR (95% CI, 1.5%–21.0%)
- Each 1% point decrease in mean HbA1c was linked to a 21.0% lower UACR (95% CI, 4.4%–34.6%)
- These findings support TIR as a clinically relevant predictor of diabetic kidney disease progression.
15 Jul, 26BMC Infect. Dis.
- Retrospective study of 390 non-cirrhotic patients achieving HBsAg clearance with pegylated interferon-alpha therapy.
- Median follow-up was 53.5 months; 4 hepatic adverse events occurred.
- All adverse events occurred in the declining HBsAb group (3.05%); none in stable or rising groups.
- HBsAb changes were inversely associated with hepatic adverse events, suggesting declining HBsAb may identify higher-risk patients.
15 Jul, 26Diabetes Res Clin Pr...
- Analysis of 15 cohort studies found a pooled T2DM incidence of 9% after GDM, the same decreased to 6.9% after publication-bias adjustment, with no heterogeneity
- Major risk factors: abnormal gestational OGTT (ES 4.28), BMI >25 kg/m² (ES 2.58), insulin use during pregnancy (ES 2.21), & family history of diabetes (ES 2.0)
- Findings support risk-stratified postpartum surveillance & early lifestyle intervention.
25 Jun, 26
Featured
16 Jul, 26
15 Jul, 26
8 Jul, 26
